Drug Interactions Database

3916 interactions from BNF 85 - Check your medicines

Source: BNF 85
lapatinib aliskiren

increases exposure

Unknown Theoretical
lapatinib alpelisib

increases exposure

Unknown Theoretical
lapatinib antihistamines,non-sedating

increases exposure

Unknown Theoretical
lapatinib apixaban

increases exposure

Unknown Theoretical
lapatinib berotralstat

increases exposure

Unknown Study
lapatinib betablockers,non-selective

increases exposure

Unknown Study
lapatinib ceritinib

increases exposure

Unknown Theoretical
lapatinib colchicine

increases exposure

Unknown Theoretical
lapatinib coumarins

increases risk of bleedingevents

Unknown Theoretical
lapatinib dabigatran

increases exposure

Unknown Theoretical
lapatinib digoxin

increases exposure

Unknown Theoretical
lapatinib edoxaban

increases exposure

Unknown Theoretical
lapatinib erlotinib

increases exposure

Unknown Theoretical
lapatinib everolimus

increases exposure

Unknown Theoretical
lapatinib fexofenadine

increases exposure

Unknown Theoretical
lapatinib fidaxomicin

increases exposure

Unknown Study
lapatinib gilteritinib

increases exposure

Unknown Theoretical
lapatinib larotrectinib

increases exposure

Unknown Theoretical
lapatinib lomitapide

increases exposure

Unknown Theoretical
lapatinib loperamide

increases exposure

Unknown Theoretical
lapatinib nadolol

increases exposure

Unknown Study
lapatinib nintedanib

increases exposure

Unknown Study
lapatinib paclitaxel

increases exposure

Unknown Study
lapatinib phenindione

increases risk of bleedingevents

Unknown Theoretical
lapatinib pibrentasvir

increases exposure

Unknown Theoretical
lapatinib relugolix

increases exposure

Unknown Study
lapatinib rimegepant

increases exposure

Unknown Theoretical
lapatinib sirolimus

increases exposure

Unknown Theoretical
lapatinib talazoparib

increases exposure

Unknown Study
lapatinib taxanes

increases exposure

Unknown Study
lapatinib theactivecomponentofsacituzumabgovitecan

increases exposure

Unknown Theoretical
lapatinib thrombininhibitors

increases exposure

Unknown Theoretical
lapatinib tigecycline

increases exposure

Unknown Anecdotal
lapatinib topotecan

increases exposure

Unknown Study
lapatinib trametinib

increases concentration

Unknown Theoretical
lapatinib venetoclax

increases exposure

Unknown Theoretical
lapatinib vincaalkaloids

increases exposure

Unknown Theoretical
larotrectinib combinedhormonalcontraceptives

decreases efficacy

Unknown Theoretical
ledipasvir amiodarone

increases risk of severebradycardiaorheartblock

Unknown Anecdotal
ledipasvir antiarrhythmics

increases risk of severebradycardiaorheartblock

Unknown Anecdotal
ledipasvir dabigatran

increases exposure

Unknown Theoretical
ledipasvir thrombininhibitors

increases exposure

Unknown Theoretical
ledipasvirwithsofosbuvir tenofovirdisoproxil

increases exposure

Unknown Study
leflunomide adefovir

increases exposure

Unknown Theoretical
leflunomide agomelatine

decreases exposure

Unknown Theoretical
leflunomide alpelisib

increases exposure

Unknown Theoretical
leflunomide aminophylline

decreases exposure

Unknown Study
leflunomide anaesthetics,local

decreases exposure

Unknown Theoretical
leflunomide anthracyclines

increases exposure

Unknown Theoretical
leflunomide antihistamines,non-sedating

increases exposure

Unknown Study
Important: This database uses data from the British National Formulary (BNF 85). It is for informational purposes only and is not a substitute for professional medical advice.